Safety and Pharmacokinetics of Alpha-1 MP (Alpha1-proteinase Inhibitor (Human), Modified Process) in Participants With Alpha1-Antitrypsin Deficiency

计划入组 4 人 · 首次发布于 2016 年 8 月 17 日

Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency

计划入组 30 人 · 首次发布于 2010 年 10 月 1 日

ALPHA LONG Study- BioMatrix AlphaTM Stent Study in Patients With CAD

计划入组 85 人 · 首次发布于 2023 年 4 月 5 日

5alpha-androstane-3alpha,17beta-diol

C₁₉H₃₂O₂

alpha,alpha-Dibromo-D-camphor

C₁₀H₁₄Br₂O

Alpha ketoglutarate

Alpha Metallurgical

United States

Alpha Republic GmbH

Austria

Cerevance Alpha, Inc.

Allogene Therapeutics Modifies ALPHA3 Trial Design Following Patient Death, Adopts Standard Lymphodepletion Protocol

Allogene Therapeutics' ALPHA3 Trial: CAR-T Therapy Guided by MRD Testing for LBCL

Allogene Pauses Cema-Cel Trial Enrollment, Prioritizes Other Programs